1001054-49-4

Basic information

• Product Name: 3-BENZYL-9-CYCLOBUTYL-3,9-DIAZASPIRO[5.5]UNDECANE
• Synonyms: 3-BENZYL-9-CYCLOBUTYL-3,9-DIAZASPIRO[5.5]UNDECANE;3,9-Diazaspiro[5.5]undecane, 3-cyclobutyl-9-(phenylmethyl)-;9-benzyl-3-cyclobutyl-3,9-diazaspiro[5.5]undecane
• CAS NO: 1001054-49-4
• Molecular Formula: C₂₀H₃₀N₂
• Molecular Weight: 298.4656
• Mol File: 1001054-49-4.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-BENZYL-9-CYCLOBUTYL-3,9-DIAZASPIRO[5.5]UNDECANE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BENZYL-9-CYCLOBUTYL-3,9-DIAZASPIRO[5.5]UNDECANE(1001054-49-4)
• EPA Substance Registry System: 3-BENZYL-9-CYCLOBUTYL-3,9-DIAZASPIRO[5.5]UNDECANE(1001054-49-4)

Safety Data

• Hazardous Substances Data: 1001054-49-4(Hazardous Substances Data)

Upstream product

• 189333-49-1 3-benzyl-3,9-diazaspiro[5.5]undecane 
• 1191-95-3 cyclobutanone 
• 189333-46-8 9-benzyl-2,4-dioxo-3,9-diazaspiro[5,5]undecane-1,5-dicarbonitrile 
• 189333-48-0 9-benzyl-3,9-diazaspiro[5.5]undecane-2,4-dione 
• 3612-20-2 1-phenylmethyl-4-piperidone 

Relevant articles and documents

SUBSTITUTED AZASPIRO DERIVATIVES

Substituted azaspiro derivatives of the Formula:are provided, in which variables are as described herein. Such compounds may be used to modulate ligand binding to histamine H3 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of central nervous system (CNS) and other disorders in humans, domesticated companion animals and livestock animals. Compounds provided herein may be administered alone or in combination with one or more other CNS agents to potentiate the effects of the other CNS agent(s). Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such ligands for detecting histamine H3 receptors (e.g., receptor localization studies).